Related Experiment Video
Updated: Jan 19, 2026
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis
S S Connolly1, F T D'Arcy, M O Corcoran
1Department of Urology, University College Hospital Galway, Galway, Ireland. steconnolly@rcsi.ie
Introduction:
The use of recombinant activated factor VII has been described for many clinical scenarios, but the value of this therapeutic agent for life-threatening haemorrhagic cystitis remains novel.
Method:
We describe a case of persistent life-threatening haemorrhagic radiation cystitis, and discuss current knowledge of this therapy including potential complications.
Result:
Control of haemorrhage was successfully achieved only after use of this agent.
Conclusion:
This therapy deserves mention in any future management algorithm devised for this condition.
